Find out more about BASE Rx and Matt Coelho’s journey to co-founding the spin-out in our latest blog 👉 https://sangerinstitute.blog/2026/05/26/from-bases-to-breakthroughs-editing-cancers-weak-spots-with-crispr/
In the latest installment of our innovator blog series, we caught up with Dr Matthew Coelho, Cancer Research UK Career Development Fellow at the Wellcome Sanger Institute. Matthew works within the Somatic Genomics programme and is co-founde...
